SREBF1 and Insulin resistance: Compensatory hyperglycemia, in turn, is not able to neutralize hepatic glucose production, whereas, in a non-resistant pathway, induces an increase in lipogenesis mediated by the overactivation of sterol regulatory element-binding protein 1 (SREBP1), which aggravates peripheral insulin resistance and favors a pro-atherogenic state [15].